BibliografíaBibliography

Guías clínicas de ASMBS, IFSO y ERAS, manejo de complicaciones después de la cirugía, resultados a largo plazo de la manga gástrica y del bypass gástrico (RYGB y OAGB), controles de laboratorio y evidencia en cirugía metabólica.ASMBS, IFSO and ERAS clinical guidelines, management of post-operative complications, long-term outcomes of sleeve gastrectomy and gastric bypass (RYGB and OAGB), laboratory monitoring and metabolic surgery evidence.

• 1. Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis. 2020;16(2):175-247. doi:10.1016/j.soard.2019.10.025. (Resumen ejecutivo publicado también en: Endocr Pract. 2019;25(12):1346-59. doi:10.4158/GL-2019-0406.) PMID 31917200 / 31682518.
• 2. Stenberg E, Dos Reis Falcão LF, O'Kane M, Liem R, Pournaras DJ, Salminen P, et al. Guidelines for perioperative care in bariatric surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations: a 2021 update. World J Surg. 2022;46(4):729-51. doi:10.1007/s00268-021-06394-9. PMID 34984504.
• 3. Salminen P, Grönroos S, Helmiö M, Hurme S, Juuti A, Juusela R, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial. JAMA Surg. 2022;157(8):656-66. doi:10.1001/jamasurg.2022.2229. PMID 35731535.
• 4. Robert M, Espalieu P, Pelascini E, Caiazzo R, Sterkers A, Khamphommala L, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299-309. doi:10.1016/S0140-6736(19)30475-1. PMID 30851879.
• 5. Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres AJ, Weiner R, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Facts. 2013;6(5):449-68. doi:10.1159/000355480. PMID 24135948.
• 6. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347:f5934. doi:10.1136/bmj.f5934. PMID 24149519.

Requerimientos de proteínas después del bypass y de la manga, vigilancia de deficiencias de micronutrientes, nutrición durante el tratamiento con GLP-1, manejo del síndrome de dumping, calendario de controles de laboratorio y factores que influyen en la adherencia a las indicaciones nutricionales.Protein requirements after bypass and sleeve, micronutrient deficiency surveillance, nutrition during GLP-1 treatment, dumping syndrome management, laboratory monitoring schedules and factors that influence adherence to nutrition guidance.

• 1. Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L. American Society for Metabolic and Bariatric Surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients. Surg Obes Relat Dis. 2017;13(5):727-41. doi:10.1016/j.soard.2016.12.018. PMID 28392254.
• 2. O'Kane M, Parretti HM, Pinkney J, Welbourn R, Hughes CA, Mok J, et al. British Obesity and Metabolic Surgery Society guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev. 2020;21(11):e13087. doi:10.1111/obr.13087. PMID 32743907.
• 3. Busetto L, Dicker D, Azran C, Batterham RL, Farpour-Lambert N, Fried M, et al. Practical recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the post-bariatric surgery medical management. Obes Facts. 2017;10(6):597-632. doi:10.1159/000481825. PMID 29207379.
• 4. Sherf Dagan S, Goldenshluger A, Globus I, Schweiger C, Kessler Y, Kowen Sandbank G, et al. Nutritional recommendations for adult bariatric surgery patients: clinical practice. Adv Nutr. 2017;8(2):382-94. doi:10.3945/an.116.014258. PMID 28298280.
• 5. Scarpellini E, Arts J, Karamanolis G, Laurenius A, Siquini W, Suzuki H, et al. International consensus on the diagnosis and management of dumping syndrome. Nat Rev Endocrinol. 2020;16(8):448-66. doi:10.1038/s41574-020-0357-5. PMID 32457534.
• 6. Bi Y, He L, Yan F, Liu Y, Zhang Y, Gong R. Personal, external, and psychological factors influencing adherence to nutrition and diet in patients undergoing metabolic/bariatric surgery: a systematic synthesis of mixed methods research. Acta Diabetol. 2024;61(9):1083-95. doi:10.1007/s00592-024-02319-9. PMID 38888635.
• 7. Esparham A, Mehri A, Dalili A, Richards J, Khorgami Z. Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: a systematic review and meta-analysis. Obes Rev. 2024;25(11):e13811. doi:10.1111/obr.13811. PMID 39134066.
• 8. Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122(1):344-67. doi:10.1016/j.ajcnut.2025.04.023. PMID 40450457.

Entrenamiento de fuerza en personas operadas, prevención de la sarcopenia durante el descenso rápido de peso, actividad física durante el tratamiento con GLP-1 (evidencia en personas no operadas), recomendaciones por etapa, suplementación con proteínas y recuperación.Resistance training after bariatric surgery, sarcopenia prevention during rapid weight loss, physical activity during GLP-1 treatment (evidence in non-surgical populations), stage-based recommendations, protein supplementation and recovery.

• 1. Bellicha A, van Baak MA, Battista F, Beaulieu K, Blundell JE, Busetto L, et al. Effect of exercise training before and after bariatric surgery: a systematic review and meta-analysis. Obes Rev. 2021;22 Suppl 4:e13296. doi:10.1111/obr.13296. PMID 34080281.
• 2. Fernández-Alonso M, Bejarano G, Creel DB, Kohl HW, Messiah SE, Altieri MS, et al. Expert-based physical activity guidelines for metabolic and bariatric surgery patients: a systematic review of randomized controlled trials. Surg Obes Relat Dis. 2025;21(5):606-14. doi:10.1016/j.soard.2024.11.005. PMID 39709279.
• 3. Oppert JM, Bellicha A, Roda C, Bouillot JL, Torcivia A, Clement K, et al. Resistance training and protein supplementation increase strength after bariatric surgery: a randomized controlled trial. Obesity (Silver Spring). 2018;26(11):1709-20. doi:10.1002/oby.22317. PMID 30358153.
• 4. Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15(3):321-35. doi:10.1159/000521241. PMID 35196654.
• 5. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK; American College of Sports Medicine. American College of Sports Medicine position stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009;41(2):459-71. doi:10.1249/MSS.0b013e3181949333. PMID 19127177.
• 6. Lundgren JR, Janus C, Jensen SBK, Juhl CR, Olsen LM, Christensen RM, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. N Engl J Med. 2021;384(18):1719-30. doi:10.1056/NEJMoa2028198. PMID 33951361.
• 7. Locatelli JC, Costa JG, Haynes A, Naylor LH, Fegan PG, Yeap BB, et al. Incretin-based weight loss pharmacotherapy: can resistance exercise optimize changes in body composition? Diabetes Care. 2024;47(10):1718-30. doi:10.2337/dci23-0100. PMID 38687506.